Neurology Topic Reviews Flashcards
(255 cards)
Why should all children with an iris coloboma have a comprehensive eye exam?
Iris coloboma may be the only externally visible part of a more extensive coloboma involving the fundus and optic nerve
Description of a coloboma?
Defect such as a gap, notch, fissure or hole
May be described as a “keyhole” appearance
May be described as an “irregular” defect
May occur in the eyelid, iris, fundus, optic nerve
What can coloboma be associated with?
Micro-opthalmia (small eye)
Nystagmus
Visual field defects (if retina involved)
What syndromes are most associated with coloboma?
CHARGE (Coloboma, Heart defects, Atresia choanae, Growth restriction, Genital abnormalities, Ear abnormalities)
T18
Walk Warburg
What is aniridia?
Partial or complete absence of the iris
Is aniridia usually unilateral or bilateral?
98% are bilateral
What other conditions are highly associated with aniridia?
Glaucoma develops in up to 75% of patients
20% of sporadic cases will develop Wilm’s tumour (gene for aniridia is very close to the gene for Wilm’s tumour)
- children with sporadic aniridia need to be screened with renal US q3-6months until age 5yo
Damage to the optic nerve with visual field loss is called:
Glaucoma
What condition should you suspect in an infant with “big, beautiful eyes”
Congenital glaucoma
Abnormal eye growth leads to large eyes
Corneal swelling is caused by cloudy cornea with photophobia and tearing
Risk factors for infantile glaucoma?
Previous intraocular surgery (including pediatric cataracts)
Uveitis
Steroid use
Syndromes
- Sturge Weber
- NF 1
- Marfan
Family history
Classic triad of glaucoma?
Epiphora (tearing)
Photophobia
Blepharospasm (eyelid squeezing in response to light)
Untreated glaucoma leads to what
Blindness
Needs urgent review by Ophtho
Definitive management is surgical
What is the classic presentation of botulism
Symmetric descending paralysis
Cranial nerve dysfunction / Bulbar palsies
Urinary retention and constipation - can precede other symptoms
Resp difficulties
DTRs can be preserved or lost
Absence of sensory deficits
Sources of exposure to Clostridium botulinum?
Classically associated with raw honey
Associated with home-canned foods, restaurant prepared foods, commercial foods sealed in plastic pouches
Can also be wound infection related → results from spore gemination and colonization of traumatized tissue by C.botulinum → similar pathophysiology to tetanus
Pathophysiology of botulism?
Irreversible inhibition of Ach release at presynaptic nerve terminal of body’s NMJs
Compare SMA vs botulism in an infant with hypotonia/ weakness?
Botulism
- should be more acute vs presenting after several weeks or months
- does not spare the cranial nerves
- descending paralysis
SMA
- more subacute presentation
- upper cranial nerves leading to most facial muscles preserved so patients have alert expression, furrowed brow, normal eye movements (but they do still have weakness of bulbar muscles)
- DTRs almost always lost
- lower limbs affected more than upper limbs
Treatment of botulism?
Baby BIG (botulism immune globulin)
Need to order from California
If patient > 1 year, can give antitoxin
Treat CLINICALLY, do not wait for stool toxin test to come back
For SMA (Spinal Muscular Atrophy), what is the inheritance pattern and gene affected?
Autosomal Recessive
SMN1 gene (biallelic deletion on chr 5q)
What is the pathophysiology of SMA (Spinal Muscular Atrophy)?
Biallelic deletion of the SMN1 gene (on chr 5q) –> results in low levels of SMN protein –> degeneration and loss of motor neurons in the anterior horn of the spinal cord and brainstem nuclei –> results in progressive weakness and atrophy .
The severe infantile rapidly progressive form of Spinal Muscular Atrophy (SMA) Type 1 occurs in 25% of SMA cases. Describe the presentation of SMA Type 1?
HINT
- Age on onset of symptoms?
- Symptom progression?
- Typical age of death if not treated?
Age on onset of symptoms?
- Presents before 6 months of age
Symptoms?
- Generalized WEAKNESS (Never able to sit, stand, walk)
- Severe SYMMETRIC FLACCID PARALYSIS, hypotonia
- ALERT EXPRESSION, furrowed brow
- NORMAL EOMs
- BULBAR MUSCLE WEAKNESS (weak cry, poor suck and swallow reflexes, pooling of secretions, tongue fasciculations, and increased risk of aspiration, FTT)
- Progressive RESP FAILURE, paradoxical breathing
- Bell-shaped chest deformity
Typical age of death if not treated?
- >65% die by age 2yr
The late infantile slower progressive form of Spinal Muscular Atrophy (SMA) Type 2 occurs in 50% of SMA cases. Describe the presentation of SMA Type 2?
HINT
- Age on onset of symptoms?
- Symptom progression?
- Typical age of death if not treated?
Age on onset of symptoms?
- Presents between 6-18months of life
Symptoms?
- Generalized WEAKNESS (Able to sit (delayed), Never able to stand or walk). PROXIMAL WEAKNESS (legs > arms)
- SPARING OF FACE AND EOMs
- FASCICULATIONS with tongue atrophy
- AREFLEXIA
- Fine tremor-like form of myoclonus in distal limbs
- DYSPHAGIA
- Resp muscle weakness & restrictive lung disease. RESP INSUFFICIENCY.
- Progressive scoliosis
- Joint contractures
Typical age of death if not treated?
- 10-40yrs, confined to wheel chair
The juvenile form of Spinal Muscular Atrophy (SMA) Type 3 occurs in 25% of SMA cases. Describe the presentation of SMA Type 3?
HINT
- Age on onset of symptoms?
- Symptom progression?
- Typical age of death if not treated?
NOTE: SMA-Type III is a mimic of Muscular Dystrophy
Age on onset of symptoms?
- Patients appear normal in infancy. Onset > 18 months - adulthood.
Symptoms?
- Muscle WEAKNESS (Able to sit and stand. Able to walk with assistance.)
- Pronounced PROXIMAL muscle weakness (presents as fall, trouble climbing stairs, waddling gait, winged scapula, gower sign)
- Eventually lose ability to stand and walk independently with time and become wheelchair dependent
- FASCICULATIONS
Typical age of death if not treated?
- Live well into adulthood
What is the gold standard test to diagnose SMA (Spinal Muscular Atrophy)? Other helpful investigations?
Genetic Testing of SMN gene deletion (Gold standard)
Other Helpful Tests:
- Muscle biopsy: Diagnostic but no longer required due to genetics. Shows circular atrophic type 1 and 2 muscle fibers.
- EMG: Diagnostic but no longer required due to genetics. Abnormal spontaneous activity with fibrillations and positive sharp waves.
- Motor nerve conduction studies: Normal (+/- mild slowing in terminal stages of the disease). Helps distinguish SMA from peripheral neuropathy.
- CK: normal or mildly elevated
SMA (Spinal Muscular Atrophy) previously had a poor prognosis. There are multiple new medications that are indicated nowadays, please describe each Mechanism of Action, Route and Side-effects of each:
- Nusinersan (Spinraza)
- Onasemnogene abeparvovec (OAX)
- Risdiplam
Nusinersan (Spinraza)
- MOA: GENE MODIFICATION drug that increases overall SMN protein production.
- Route: Intrathecal loading dose + q4mo intrathecal maintenance doses.
- Side-effects: Thrombocytopenia, Coagulopathy, Renal toxicity.
- Patient Age: Approved for patients <2mo
Onasemnogene abeparvovec (OAX)
- MOA: GENE REPLACEMENT therapy via recombinant AAV9 that gives you an SMN gene.
- Route: Single IV infusion
- Side-effects: Liver injury, Thrombocytopenia, Inc troponin.
- Patient Age: Approved for patients <2mo
Risdiplam
- MOA: SMN2 directed RNA splicing modifier resulting in increased full-length SMN protein.
- Route: PO daily
- Patient Age: Approved for patients >2mo